Published: August 2025 | Last updated: May 2026
Why does Delaware rank so high for chlamydia, and what should I do about it?
Dense young-adult networks around Delaware's two universities, silent infections, and uneven clinic access keep Delaware's chlamydia rate above the U.S. average. CDC recommends annual screening for anyone sexually active under 25. After a possible exposure, an at-home rapid swab is reliable from about day 14. A single course of antibiotics cures the infection.
Delaware is a small state with an outsized chlamydia problem. Surveillance reports from the U.S. Centers for Disease Control and Prevention place it consistently in the top tier of U.S. states by chlamydia rate, and the trajectory has been upward, not flat. The headline numbers don't tell the whole story, though. Better screening surfaces more cases (which is good), but persistent transmission keeps the case pipeline refilling (which is the real problem). Most of the people fueling the figure feel completely fine on the day they would have tested positive.
This guide pulls together the why, the where, and the what-to-do. It draws on CDC surveillance data, the CDC's 2021 STI treatment guidelines, NHS patient resources, the Delaware Division of Public Health, and Delaware's own consent statute. The aim is practical: know whether you should test, how soon, where to go, what kind of test, and what to do with the result.
The Numbers Behind Delaware's Ranking
Chlamydia is the most commonly reported bacterial sexually transmitted infection in the United States, and Delaware is no exception. Delaware has reported chlamydia rates consistently above the U.S. average across recent CDC surveillance cycles, with the heaviest burden falling on people aged 15 to 24 (CDC STI surveillance). The state's position has stayed in the higher-rate group of states for multiple reporting cycles, even as exact rank shifts year to year.
Two things are happening at once. Better screening uncovers infections that previously went undetected; this is real progress. At the same time, the underlying transmission rate is high enough that cases keep refilling the pipeline as fast as treatment empties it. Public-health staff describe the same pattern: more positives are showing up because more people are being tested, but repeat positives in the same individuals reveal that partners aren't always getting treated at the same time. When that happens, an infection cycles back into the community before the original case is fully resolved.
Delaware's geography concentrates the effect. Roughly half of Delawareans live in or commute through New Castle County, which compresses sexual networks into a single dense corridor. The University of Delaware in Newark adds more than 24,000 students to that corridor every fall and spring, and Delaware State University in Dover adds another active young-adult population. Sussex County, by contrast, is rural and underserved, where mobile clinic visits cover only a fraction of the geography and clinic hours rarely match shift-worker schedules.
- Above the U.S. average. Delaware has stayed in the higher-rate group of states for chlamydia across recent CDC surveillance cycles.
- Concentrated in young adults. People aged 15 to 24 account for the largest share of new diagnoses, mirroring the national pattern but amplified by Delaware's college-town density.
- Geographic clustering. New Castle County's population density, combined with student populations in Newark and Dover, drives much of the state-level rate.
Why Cases Spread Quietly
The single most important fact about chlamydia is that most people who have it don't know they have it. Most chlamydia infections produce no obvious symptoms, especially in the first weeks after exposure (CDC: About Chlamydia). When symptoms do appear, they are often mild enough to be brushed off as a yeast infection, a mild urinary tract infection, or post-period spotting. The NIH MedlinePlus chlamydia overview describes the same pattern of mild or absent early symptoms.
Composite reader profiles surface the same pattern over and over. A 23-year-old in Wilmington feels nothing for weeks. No fever, no discharge, no burning. He notices a dull ache in his lower abdomen and chalks it up to stress or bad takeout. The cue comes from a text message: a recent partner has just tested positive and wants him to know. He does not believe it at first. "I felt completely fine. No symptoms, nothing. I thought sexually transmitted infections were supposed to be obvious." He tests positive, takes the prescribed antibiotic course, and notifies the two people he has been with since his last screen. The hardest part, he later tells a friend, has less to do with the diagnosis and more with the cultural assumption that a positive result must mean he did something wrong.
Silent infections are exactly why annual screening matters more than waiting to feel something wrong. Without routine testing, a single asymptomatic case can sit in a small community for months, transmit through several partners, and surface only when one of those partners gets pregnant, has surgery, or shows up at a clinic for an unrelated visit. The bacterial load doesn't announce itself. It just transmits.
The site-specific nature of chlamydia also gets missed. A urine-only or genital-only screen can miss infection in the throat or rectum, which means anyone having oral or receptive anal sex needs site-specific swabs, not just a urine sample or a vaginal swab. The CDC's 2021 STI Treatment Guidelines spell this out (CDC STI Treatment Guidelines: Chlamydial Infections).
Reinfection risk after a first case is genuinely high. Most positive-after-treatment results are not treatment failure; they are a partner who was never treated, or a new partner already infected, or both. Retesting about three months after treatment is the standard recommendation regardless of symptoms.
CDC clinical guidance is direct: chlamydia often produces no noticeable symptoms, which means a person who feels fine can still be infected and transmit the bacterium (<a href="https://www.cdc.gov/chlamydia/about/index.html" target="_blank" rel="noopener noreferrer">CDC: About Chlamydia</a>). The practical implication: screening, not symptom-watching, is the only reliable way to know your status.
Geography and Demographics: Why a Small State Posts Big Numbers
Delaware's compact size cuts both ways. Public-health teams can theoretically reach every county within a couple of hours; on the other hand, social and sexual networks overlap heavily, which speeds the spread of any communicable infection. Three population pockets carry the heaviest burden.
- Newark and the University of Delaware corridor. A student body topping 24,000 plus a steady inflow of out-of-state visitors creates a fast-turnover network. Fall and spring semesters drive seasonal upticks in clinic test volume.
- Wilmington and surrounding New Castle County neighborhoods. Density, limited youth-friendly clinic hours, and concerns about being recognized at the local health center push people toward delay.
- Sussex County and rural southern Delaware. Long distances to clinics, seasonal tourism in beach communities, and a thinner network of sliding-scale providers keep undiagnosed infections circulating longer than they should.
None of these patterns are unique to Delaware. They show up in any small or medium state with one big university town and a wide rural belt. What's distinctive is the combined density: when sexual networks in three small population centers overlap during commuting, summer tourism months, and breaks in the academic calendar, infections move faster than contact-tracing capacity.
Density is also why partner treatment matters more in Delaware than in a larger state. If a person tests positive in Wilmington and their partner is in Dover, the time between the positive result and that partner's first dose of antibiotics determines how many further transmissions get prevented. Anything that shortens the gap (faster results, easier partner testing, faster partner treatment) directly lowers the state-wide rate.
- Rural Sussex County. Long distances and limited mobile-clinic visits mean undiagnosed infections circulate longer than they should before treatment.
- Men under 25 across the state. Without a routine reproductive-health visit, many never see a provider who would suggest an STI screen, so infections in this group are systematically missed.
- Shift workers and students with packed schedules. Standard clinic hours do not match a 7-to-3 shift, evening retail, or a class block ending at 5 p.m.
Where to Get Tested in Delaware
Delaware offers more chlamydia testing options than most residents realize, spread across public clinics, federally qualified health centers, pharmacies, college student services, and private at-home kits.
The Delaware Division of Public Health operates STI clinics in Wilmington, Dover, and Georgetown that offer free or low-cost testing on a sliding scale. Walk-in availability varies by location, so calling ahead is worth the two minutes. Federally qualified health centers across all three counties (New Castle, Kent, Sussex) accept Medicaid and offer reduced-fee services for the uninsured.
Planned Parenthood operates a health center in Wilmington with appointment-based testing, and college-affiliated clinics (University of Delaware Student Health Services, Delaware State University Health Services) provide on-campus testing for enrolled students. Both campus clinics will see students confidentially, including when a parent's insurance is in play; ask the front desk about confidential billing options before scheduling.
Pharmacy-based testing has expanded in the state. Both CVS MinuteClinic and select Walgreens locations offer urine-based or swab chlamydia testing as part of standard STI panels. Cost varies by insurance, but a self-pay STI screening typically falls in the $80 to $150 range depending on location and panel size.
For readers who would rather screen privately than navigate the in-state clinical landscape, an at-home chlamydia test is one more pathway. Whether you test at a clinic or at home, a positive chlamydia result needs to be followed by a prescription antibiotic course. Some telehealth services that work with Delaware residents will issue a prescription based on a verified positive home result; others require an in-person visit. Confirm the follow-up pathway before you order a kit, so you have a treatment plan ready if the result comes back positive.
- DPH STI clinics (Wilmington, Dover, Georgetown). Free or low-cost sliding-scale testing; walk-in availability varies by site.
- Federally qualified health centers (all three counties). Medicaid accepted; reduced-fee services for the uninsured.
- Planned Parenthood Wilmington. Appointment-based testing; confidential billing on request.
- Campus clinics (University of Delaware, Delaware State University). On-campus testing for enrolled students; ask about confidential billing.
- CVS MinuteClinic and select Walgreens. Urine or swab testing as part of STI panels; self-pay typically $80 to $150.
- At-home rapid swab kits. Plain packaging, no insurance trail, result on the cassette in roughly fifteen minutes.
How At-Home Testing Closes the Access Gap
If clinic access is the barrier, the obvious lever is to lower the friction of getting a sample collected at all. At-home rapid swab tests do exactly that. A kit ships in plain packaging, the user collects a self-swab in private, and the result reads on a cassette in about fifteen minutes (or, for mail-back lab options, returns within a few days).
Privacy is the headline benefit, but it is not the only one. People who would put off a clinic visit for weeks will often complete an at-home test within 48 to 72 hours of ordering it. That speed compresses the gap between potential exposure and a definitive answer, which is exactly the window that lets chlamydia transmit onward in tight social networks.
A few practical points to set expectations realistically:
- Sample type matters. Our at-home chlamydia test uses a self-collected vaginal or penile swab. If the relevant exposure was oral or receptive anal, a clinician should collect a site-specific throat or rectal swab; we do not sell that.
- Test technology matters. Our home test is a lateral-flow rapid test, not a laboratory NAAT. Laboratories use NAAT (nucleic acid amplification testing) for higher analytical sensitivity in low-bacterial-load infections. The two are complementary, not equivalent. A positive result at home is worth confirming through a clinic, and a negative at home in someone with strong symptoms or a known recent exposure is worth retesting through a lab in about two weeks.
- Window period matters. Most rapid tests reach reliable accuracy from about day 14 after exposure (more on this below).
STD Rapid Test Kits sells the lateral-flow rapid swab kits described in this article. The site recommends products based on which kit fits the reader's exposure and concern, not commercial benefit.
How Long After Exposure Should You Test?
Probably the single most common reader question is, "how soon after sex can I test?" The answer depends on the test type and the bacteria's reproductive cycle. Test too early and the result can be falsely negative even when an infection is starting.
For chlamydia specifically, laboratory NAAT tests, the laboratory gold standard described in CDC STI treatment guidelines, can usually detect a new infection one to two weeks after exposure, and sometimes a few days earlier. Most home rapid lateral-flow tests follow a similar window and become reliably accurate from around day 14 onward. Testing earlier than that can miss an early infection.
If exposure was less than a week ago and you're symptom-free, the strongest move is to wait until day 14 and then test. If you are already showing symptoms (unusual discharge, burning urination, pelvic discomfort, post-coital bleeding), see a clinician now rather than waiting for a test window to close. Treatment can begin before lab confirmation if the clinical picture is clear enough, and a delay just lets a treatable infection continue.
If your first test is negative and a partner has confirmed they tested positive, a follow-up test two to three weeks later catches infections that were below detection threshold the first time. CDC guidance also recommends a retest about three months after treatment for anyone diagnosed with chlamydia, primarily to catch reinfection from an untreated partner.
| Time Since Exposure | Reliability of Result | Recommendation |
|---|---|---|
| 0 to 6 days | Likely false negative even if infected | Wait until day 14, then test |
| 7 to 13 days | May detect heavier infections; false negatives still common | Acceptable to test, but plan to retest at day 14 |
| 14 days and beyond | Reliable for most lateral-flow rapid tests and laboratory NAATs | Test now; retest about 3 months after any treatment |
| Symptoms present at any point | Clinical picture supports earlier testing and treatment | See a clinician promptly, do not wait for a window |
Why Stigma Slows Testing in a Small State
Stigma is the second engine behind Delaware's high case rate, and it operates at every step of the infection chain. People who suspect they might have been exposed delay testing because they don't want the result on their chart. People who test positive delay telling their partners because they fear judgment. People who hear about a friend's diagnosis say nothing, even though knowing might prompt their own screen.
Public-health research on this is unambiguous. When stigma reduces testing, prevalence rises. When testing rises, prevalence falls. The most effective state-level interventions focus on willingness, getting more people to step into a clinic or order a home kit for routine screening rather than waiting for symptoms.
A few specific framings help break the loop. Testing belongs in the same category as routine health maintenance like a dental cleaning or a blood-pressure check, just applied to a different body system. A positive result is a snapshot of bacterial presence in tissue on a specific date; treatment is a prescription course; the diagnostic moment itself is short. Telling a recent partner is the same favor you would want them to do for you, framed as logistics rather than as confession.
The fear that someone might recognize you at the local clinic is real in a state Delaware's size, and it is one of the reasons the at-home option matters. It also helps to remember that clinic staff in Wilmington, Dover, and Georgetown process hundreds of STI tests a year; to them, the visit is routine paperwork.
What Untreated Chlamydia Can Actually Do
The biological mechanism behind chlamydia complications is straightforward. When the bacterium Chlamydia trachomatis isn't cleared with antibiotics, it can ascend the reproductive tract and cause inflammation in deeper tissues. The clinical name for that condition in people with a uterus is pelvic inflammatory disease, or PID.
Per CDC clinical guidance, untreated chlamydia is one of the leading causes of preventable PID, and PID is in turn a leading cause of preventable infertility in the United States. PID can also produce chronic pelvic pain and increase the risk of ectopic pregnancy, a potentially life-threatening condition in which a fertilized egg implants outside the uterus. Detailed clinical context appears in the CDC 2021 STI Treatment Guidelines, with broader symptom and complication context available from the Mayo Clinic chlamydia overview.
People with testicles are not immune. Untreated chlamydia can cause epididymitis, an inflammation of the tube at the back of the testicle that carries sperm, which the NHS chlamydia guide lists among the complications of untreated infection in men. Epididymitis is painful and, in rare cases, can affect fertility. Reactive arthritis is a less common downstream complication that can follow chlamydia in either sex, producing joint inflammation weeks after the original infection.
Chlamydia during pregnancy carries additional risks. CDC clinical guidance notes that untreated maternal chlamydia can lead to preterm delivery and can be passed to the newborn during birth, where it can cause neonatal conjunctivitis or pneumonia in the infant. Standard prenatal screening in the U.S. includes a first-trimester chlamydia test for this reason.
Chlamydia is one of the most reliably curable bacterial infections in clinical medicine. A course of doxycycline taken over seven days, or single-dose azithromycin in specific clinical scenarios such as pregnancy, clears the infection in nearly all patients per CDC STI treatment guidelines. The shorter the gap between exposure and a result, the fewer onward transmissions happen, and the lower the chance any of these complications gets a chance to develop.
Most people who have chlamydia have no symptoms. If left untreated, chlamydia can cause serious health problems, including pelvic inflammatory disease, which can lead to infertility.
Privacy and Consent: Delaware's Minor Consent Law
One of the underused facts in Delaware sexual-health law is that minors aged 12 and older can consent to STI testing and treatment without parental approval (Delaware Code, Title 13, Chapter 7, Subchapter I). The same statute protects the resulting medical records.
For teens and college students, this is a meaningful protection. Fear of a parent finding out is consistently one of the top reasons younger Delawareans delay or avoid testing. The law removes the legal piece of that fear. Clinics will typically work with patients who request that statements not be mailed home or that insurance be billed to a confidential address; ask directly when scheduling.
For at-home testing, the privacy picture is even simpler. The kit ships in plain packaging. No insurance is required. No clinic appointment leaves a paper trail. For someone weighing whether to test at all because of who might find out, that single change can be the difference between testing now and not testing for months.
- State minor-consent law. Anyone aged 12 or older can consent to STI testing and treatment without a parent's involvement.
- Confidential clinic billing. Most clinics will work with a patient who asks that statements not be mailed home, or that insurance be billed to a confidential address.
- At-home testing. Plain packaging, no insurance trail, no clinic appointment.
Sample Type Matters: Match the Test to the Exposure
One of the recurring sources of false-negative results is testing the wrong anatomic site. Chlamydia can colonize the genitals, the rectum, and the throat independently. A clean genital screen does not rule out a throat or rectal infection if the exposure happened there.
The table below maps the most common exposure scenarios to the right test. Anywhere our home kit does not cover, a clinic visit is the right route; we do not sell pharyngeal or rectal swabs, and substituting a genital swab for a different anatomic site is not appropriate.
| Exposure Type | Right Test for Chlamydia | Available at Home Through Us? |
|---|---|---|
| Vaginal or penile sex (no oral or anal) | Self-collected vaginal or penile swab | Yes, our chlamydia rapid swab |
| Giving or receiving oral sex | Pharyngeal (throat) swab, clinician collected | No, see a clinic |
| Receptive anal sex | Rectal swab, clinician collected | No, see a clinic |
| Multiple exposure routes in one encounter | Site-specific swabs at each anatomic site involved | Partial, our home test covers the genital site only |
Prevention That Fits Real Life
Delaware's numbers will not drop because of awareness posters alone. They drop when prevention fits into actual schedules and actual anxieties. The shortlist of changes that move the needle, without moralizing:
- Annual screening. Make it a calendar event every 6 to 12 months while sexually active, sooner with a new partner.
- Site-specific testing. If you have oral or anal sex, ask for throat and rectal swabs; a urine-only or vaginal-only screen can miss those sites.
- Condoms and dental dams more often. Used more often, not perfectly always. Even partial increases lower risk in a network.
- Faster partner treatment. If you test positive, loop partners in within days, not weeks. Ask a clinician about expedited partner therapy.
- Three-month retest. Recheck about three months after treatment to catch reinfection early. Reinfection is common and is not failure.
Talking to Partners and Retesting
If a chlamydia test comes back positive, two things happen at the same time: treatment starts, and the conversation with anyone who may have been exposed begins. Both are necessary. Treatment without partner notification creates a ping-pong dynamic in which two people keep reinfecting each other for months.
The conversation is uncomfortable but rarely catastrophic. Most partners receive a "you might want to get tested" message with relief or thanks rather than anger. The alternative (finding out from a complication) is far worse for everyone. A short, neutral message works: "I tested positive for chlamydia. You may not have any symptoms, but you should test and start treatment."
Treatment itself is straightforward. The CDC's 2021 treatment guidelines recommend doxycycline 100 mg twice a day for seven days as the preferred regimen for uncomplicated urogenital chlamydia, with single-dose azithromycin as an alternative for specific clinical scenarios such as pregnancy (CDC STI Treatment Guidelines). Two follow-up steps matter after treatment:
- Wait seven days after the last antibiotic dose before resuming sex with a treated partner, or until both of you have completed treatment, whichever is later. Earlier than that and either of you can pass viable bacteria back.
- Retest at about three months after treatment, regardless of symptoms. Most positive-after-treatment results are reinfection from an untreated partner or a new exposure; catching it again at three months prevents another long silent stretch.
Delaware also permits expedited partner therapy in many situations, which is a clinician-prescribed antibiotic course sent directly to a partner's pharmacy without a separate clinic visit for that partner. Ask your provider directly. If a direct conversation feels unsafe, the Delaware Division of Public Health can assist with anonymous partner notification that contacts partners without revealing your name. Because chlamydia and gonorrhea so often travel together, partners testing for one should usually test for both at the same time.
How an At-Home Chlamydia Swab Works, Step by Step
For readers who want to know exactly what to expect from ordering through to result:
- Order. The single-infection chlamydia kit, a chlamydia plus gonorrhea combo, or one of the broader panels ships in plain, unbranded packaging.
- Collect. An illustrated guide walks through self-collection. The kit uses a vaginal or penile swab; the entire collection process takes about two minutes once the kit is open.
- Read. The cassette displays a result line in about fifteen minutes. The kit's instructions explain what a control line versus a test line indicates and what to do for indeterminate readings.
- If positive. See a clinician for confirmation and treatment. Most providers will treat presumptively on a positive at-home result and order a confirmatory laboratory NAAT.
- Retest. Plan to retest about three months after treatment ends, even if symptoms have resolved.
For oral or rectal exposure specifically, a clinic-administered site-specific swab is the right test; we do not sell those. The at-home rapid kit covers the most common exposure route, genital sex, and clinic care fills the gaps where home testing does not reach.
What to Do Next
If you're sexually active in Delaware and you haven't been screened in the last year, the protective move is to test now and then set a regular interval after that. Choose the pathway most likely to get you actually following through: a state clinic if cost is the barrier, a pharmacy if convenience matters most, an at-home kit if privacy is the deciding factor. If you test negative and have no specific concerns, mark a calendar reminder for a year out, or sooner if you have a new partner before then. Setting that date on your calendar once is the single habit that keeps you ahead of any new exposure.
FAQs
- Why does Delaware have such a high chlamydia rate?
- Delaware posts one of the highest chlamydia rates per capita in the United States. The drivers are demographic (a young population clustered around two major universities), structural (limited rural clinic hours and reluctance to use local clinics where someone might be recognized), and biological (most cases produce no symptoms and go undetected for weeks or months). Improvements in screening have raised the visible case count, but the underlying transmission rate is what keeps the ranking high.
- How often should I test for chlamydia in Delaware?
- If you are sexually active and under 25, the CDC recommends annual chlamydia screening. Test sooner than annually if you have a new partner, a partner tests positive, or you have unprotected sex with multiple partners. For men who have sex with men, every 3 to 6 months is the standard interval. After any treated chlamydia infection, retest about three months later to catch reinfection early.
- Where can I get tested for chlamydia in Delaware?
- Options include Delaware Division of Public Health STI clinics in Wilmington, Dover, and Georgetown; federally qualified health centers across all three counties; Planned Parenthood in Wilmington; University of Delaware and Delaware State University student health services; pharmacy-based testing at select CVS MinuteClinic and Walgreens locations; and at-home self-collected swab kits delivered by mail. Self-pay STI screening at a pharmacy typically falls in the $80 to $150 range.
- Can I have chlamydia and not know it?
- Yes, and that's the most common scenario. Per CDC clinical guidance, the majority of chlamydia infections produce no noticeable symptoms, especially in the first weeks after exposure. That's why screening, rather than symptom-watching, is the only reliable way to know your status in a high-prevalence state like Delaware.
- Can I get chlamydia from oral sex?
- Yes. Pharyngeal (throat) chlamydia is real, and it is often mild or symptomless, which is why it is missed. If you have oral sex, ask a clinician for a throat swab specifically; a urine-only or genital-swab screen will not detect throat infection. We do not sell at-home pharyngeal swabs, so a clinic visit is the right route here.
- Are at-home rapid chlamydia tests as accurate as lab tests?
- For routine genital screening from day 14 onward, the lateral-flow test is accurate enough to act on. Where lab NAAT has the edge is in very early or low-bacterial-load infections that haven't yet built enough bacterial load for a rapid strip to pick up. Use the home kit as a fast screen, confirm any positive at a clinic before treatment, and retest after two weeks if symptoms persist despite a negative result.
- Can a 12-year-old test confidentially in Delaware?
- Yes. Delaware Code, Title 13, Chapter 7 lets anyone aged 12 or older consent to STI testing and treatment without parental approval, and the resulting medical records are protected. Some clinics will also work with patients who request that statements not be mailed home or that insurance be billed to a confidential address. At-home kits add another layer of privacy because no insurance or appointment paper trail is involved.
- What happens if chlamydia goes untreated?
- In people with a uterus, untreated chlamydia can lead to pelvic inflammatory disease, which raises the risk of infertility, ectopic pregnancy, and chronic pelvic pain. In people with testicles, untreated infection can cause epididymitis and, more rarely, fertility issues. During pregnancy, untreated chlamydia can lead to preterm delivery and can be passed to the newborn at birth, causing neonatal conjunctivitis or pneumonia. Treatment is straightforward (usually a single course of antibiotics), so early testing prevents nearly all of these outcomes.
- Can I test positive again after treatment?
- Yes, and most positive-after-treatment results are reinfection rather than treatment failure. The usual culprits are an untreated partner who reinfects you, or a new partner who is already infected. That is why retesting at about three months after treatment is standard, and why partner treatment matters as much as your own. Use condoms or dental dams more consistently while a partner is being tested and treated, and avoid sex for at least seven days after the last antibiotic dose.
- U.S. Centers for Disease Control and Prevention. About Chlamydia: overview, asymptomatic infections, transmission, and routine screening recommendations.
- U.S. Centers for Disease Control and Prevention. 2021 Sexually Transmitted Infections Treatment Guidelines, chapter on chlamydial infections (treatment regimens, partner therapy, retesting recommendations, PID, neonatal chlamydia).
- U.S. Centers for Disease Control and Prevention. STI Statistics surveillance hub, the source for national reportable STI data including chlamydia case rates by state and population group.
- U.K. National Health Service. Chlamydia overview: symptoms, transmission, testing, treatment, and complications including epididymitis in men.
- Mayo Clinic. Chlamydia trachomatis: symptoms and causes, including complications such as pelvic inflammatory disease and epididymitis.
- NIH MedlinePlus. Chlamydia Infections: patient-facing overview of symptoms, testing, and treatment.
- Delaware Department of Health and Social Services, Division of Public Health. State STI surveillance data, free public testing clinic locations in Wilmington, Dover, and Georgetown, and partner notification services.
- Delaware Code, Title 13, Chapter 7, Subchapter I. Consent of minor (12 and older) to medical, dental, and surgical care, including STI testing and treatment (ยง 710).
